ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

KNTE Kinnate Biopharma Inc

2.65
0.00 (0.00%)
Pre Mercado
Última actualización: 19:00:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Kinnate Biopharma Inc KNTE NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 2.65 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.65
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/4/202408:00GLOBEXOMA Corporation Announces Closing of Tender Offer
19/3/202415:05GLOBEXOMA Announces Calculation of Additional Price Per Share and..
05/3/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202416:27EDGAR2Form SC 14D9 - Solicitation, recommendation statements
01/3/202407:53EDGAR2Form SC14D9C - Written communication relating to third party..
01/3/202407:50EDGAR2Form 8-K - Current report
01/3/202407:35PRNUSKinnate Biopharma Inc. Sells Its Investigational Pan-RAF..
01/3/202407:30GLOBEKinnate Biopharma Inc. Sells Its Investigational Pan-RAF..
21/2/202405:01EDGAR2Form SC14D9C - Written communication relating to third party..
16/2/202416:57PRNUSALERT: Rowley Law PLLC is Investigating Proposed Acquisition..
16/2/202409:46PRNUSKuehn Law Encourages KNTE, FANG, HAYN, and VINE Investors to..
16/2/202408:10EDGAR2Form 8-K - Current report
16/2/202407:00GLOBEXOMA Enters into Agreement to Acquire Kinnate Biopharma for..
14/2/202408:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
16/1/202415:05EDGAR2Form 8-K - Current report
05/12/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202308:00EDGAR2Form 8-K - Current report
09/11/202315:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:14EDGAR2Form 8-K - Current report
09/11/202315:05GLOBEKinnate Biopharma Inc. Reports Third Quarter 2023 Financial..
18/9/202315:28EDGAR2Form 8-K - Current report
18/9/202315:10GLOBEKinnate Biopharma Inc. Announces Pipeline Updates, Strategic..
06/9/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202315:48EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202315:16EDGAR2Form 8-K - Current report
08/8/202315:05GLOBEKinnate Biopharma Inc. Reports Second Quarter 2023 Financial..
28/7/202315:06EDGAR2Form 8-K - Current report
01/6/202315:05GLOBEKinnate Biopharma Inc. to Participate in Upcoming Investor..
11/5/202315:05GLOBEKinnate Biopharma Inc. Reports First Quarter 2023 Financial..

Su Consulta Reciente

Delayed Upgrade Clock